Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-26-009657
Filing Date
2026-03-25
Accepted
2026-03-24 19:17:24
Documents
21

Document Format Files

Seq Description Document Type Size
1 FORM S-3 acrx20260324_s3.htm   iXBRL S-3 268988
2 EXHIBIT 5.1 ex_936601.htm EX-5.1 12873
3 EXHIBIT 23.1 ex_936452.htm EX-23.1 2396
4 EXHIBIT FILING FEES ex_936453.htm   iXBRL EX-FILING FEES 24854
9 cooley.jpg GRAPHIC 2863
10 logo.jpg GRAPHIC 2995
  Complete submission text file 0001437749-26-009657.txt   603192

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tlph-20251231.xsd EX-101.SCH 5409
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20251231_def.xml EX-101.DEF 11721
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20251231_lab.xml EX-101.LAB 25278
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20251231_pre.xml EX-101.PRE 11936
25 EXTRACTED XBRL INSTANCE DOCUMENT acrx20260324_s3_htm.xml XML 2341
26 EXTRACTED XBRL INSTANCE DOCUMENT ex_936453_htm.xml XML 4515
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

EIN.: 412193603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-294580 | Film No.: 26787945
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)